Critique of FDA’s latest SSRI Data Analysis
PRESS BRIEFING: Critique of FDA Report: “Clinical review relationship between antidepressant drugs and suicidality in adults, 2006” http://www.fda.gov/ohrms/dockets/ac/06/briefing/2006-4272b1-index.htm
-
-
FDA Rescinds–Advisory Hearing on Suicide Opened to Speakers WhoWere Locked Out
Two Press Briefings are planned to demonstrate the multiple flaws in FDA's methodology and to provide credible science-based information.
-
Another Psych Drug Demonstrated to be USELESS / HARMFUL_Yale /Columbia
"the first-ever randomized, placebo-controlled trial for the alleviation of post-traumatic stress disorder (PTSD)" reports: "we found that it really offered patients no benefits of any symptoms." [1]
-
New Schizophrenia Drugs No Better Than CheaperGenerics_Bloomberg_WashPost
U.S. State Attorneys General should investigate the fraudulent marketing of the atypical neuroleptic drugs-and FDA's role in helping conceal the truth.
-
NIH Secrets Government Funded Data Concealment_Lenzer-New Republic
An eye opening article by Jeanne Lenzer, “NIH Secrets,” in The New Republic (below), should make the new Congress sit up and take notice!
-
Flu Vaccine–where is the evidence?
This is an addendum to yesterday's Infomail in which we disseminated disinformation issued by the U.S. Center for Disease Control (CDC). www.ahrp.org/cms/content/view/396/80
-
Conflict of Interest | Corrupt Practices | Gov. Medical Malfeasance | Government Agencies | Pharma Corrupt Influence
Former State Pharmacist (Pennsylvania) Faces Criminal charges
Steven Fiorello, former Chief Pharmacist for the State of Pennsylvania, was arraigned on on Tuesday, November 21, 2006, on Felony and Misdemeanor charges related to his accepting money from drug companies whose drugs he put on the state Formulary.
-
Separating the Facts from the Propaganda_Latest Findings of Depression Study
Today's news report circulated by the media about the negative findings of a much touted, but uncontrolled observational study of depression (STAR*D) promotes the business interests of SSRI antidepressant drug manufacturers.
-
NIMH Chief Child/Adoles Research Blows Wind out TeenScreen Sails_ Los Angeles Times
"Some politicians, public health officials, mental health activists and pharmaceutical companies have worked to establish mental-health screening programs in schools and the community….Researchers and clinicians, meanwhile, say they are far from having developed accurate predictors of a child developing depression. The younger the child, the murkier the crystal ball."
-
Columbine shooting victim sues Solvay Pharma – Insight
September 3, 2002 Columbine shooting victim sues Solvay Pharmaceuticals – Insight Magazine FYI Insight Magazine reporter, Kelly Patricia O’Meara, reports in (below) that 19- year old Mark Taylor, a victim of the shooting spree at Columbine high school in 1999, spent nearly two months in the hospital plus 3 years…
-
Dr. Kramer – All Things They Taught Us That Were Wrong in Psychiatry
Dr. Kramer – All Things They Taught Us That Were Wrong in Psychiatry Thu, 15 Sep 2005 In a 2004 column, a psychiatrist who engages in “myth busting” inadvertently confirms that psychiatry is given to prescribing mood swings. He acknowledges that sometimes effective treatments are dropped (benzodiazepines) for new ones…
-
Cash Interests Taint Drug Advice – NATURE / Death a Risk of Antipsychotics – AP
Cash Interests Taint Drug Advice – NATURE / Death a Risk of Antipsychotics – AP Sun, 23 Oct 2005 An investigation by the journal, NATURE (the largest of its kind) reveals that not only do conflicts of interest taint the conduct and outcome of clinical trials, the authors who formulate…